Published: November 2nd 2024 | Updated: November 6th 2024
Making the Cost of IBD Care Sustainable
Published: October 31st 2024 | Updated: November 6th 2024
Panelists Stress Stakeholder Education to Build Confidence in Biosimilars
Published: October 25th 2024 | Updated: November 6th 2024
Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf
Published: October 26th 2024 | Updated: November 6th 2024
Veterans’ Experience With Infliximab Biosimilars for IBD Treatment
Published: October 20th 2024 | Updated: November 6th 2024
Addressing Hesitance in Biosimilar Adoption
Published: October 19th 2024 | Updated: November 6th 2024
Phase 3 Study Reports Similar Efficacy Between SB17, Stelara in Psoriasis